Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00059397 · ClinicalTrials.gov registry record
Hepatitis C: Grading and Staging by MR
A clinical trial of Hepatitis, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- Completed
- Registry status
- 80
- Enrollment target
- 1
- Study location
NCT00059397: Completed study of Hepatitis, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
NCT00059397 is a study of Hepatitis that has completed, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The registered enrollment target is 80 participants, below the 254-participant average among 5 other Hepatitis trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00059397, a study of Hepatitis, has completed, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
To compare MR imaging findings with biopsy for grading and staging early hepatitis C.
Conditions Studied
Study Locations (1)
Pennsylvania
- Thomas Jefferson University Hospital - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2003-04 |
What the finished NCT00059397 record still lists
NCT00059397 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 254-participant average among 5 other Hepatitis trials with a reported enrollment target (69% lower).
The record links to 1 condition, with Hepatitis appearing as the primary indexed condition, and to 0 interventions.
NCT00059397 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00059397 about?
NCT00059397 is a clinical study titled "Hepatitis C: Grading and Staging by MR". To compare MR imaging findings with biopsy for grading and staging early hepatitis C.
What is the current status of trial NCT00059397?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2003-04.
What conditions does trial NCT00059397 study?
This clinical trial studies the following conditions: Hepatitis.
Who is sponsoring clinical trial NCT00059397?
This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00059397 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hepatitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
RECRUITING · Phase 3
-
Treating Nonalcoholic Steatohepatitis With Pioglitazone
COMPLETED · Phase 2
-
Manhattan HIV/Hepatology Brain Bank
COMPLETED
-
Merimepodib (MMPD) in Triple Combination for the Treatment of Chronic Hepatitis C
COMPLETED · Phase 2
-
The Health Access and Recovery Peer Program
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia